Internal Medicine · Alhambra, CA
NPI
1861594228
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
35 Garfield Ave.
Alhambra, CA, 91801
Phone (626) 458-8818
Groups this clinician bills Medicare through
Medicare paid, 2024
$185K
5,575 services
Medicare patients, 2024
393
Average age 76
Drug cost, 2024
$2.4M
14,144 prescriptions
Company payments, 2025
$1,461
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thein Htay was code J0153 (injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)), 3,000 times for 50 patients. In total Thein Htay billed 5,575 services in 26 codes, and Medicare paid $185K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-03-04.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0153 Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | Office | 3,000 | 50 | $0.38 | $1,137 |
| 93000 Electrocardiogram | Office | 722 | 299 | $11.24 | $8,115 |
| 99214 Office E&M - Established | Office | 720 | 313 | $99.16 | $71K |
| A9505 Thallium tl-201 thallous chloride, diagnostic, per millicurie | Office | 380 | 95 | $29.19 | $11K |
| 93306 Echocardiography (TTE/TEE) | Office | 127 | 126 | $165.27 | $21K |
| 99213 Office E&M - Established | Office | 118 | 83 | $73.65 | $8,690 |
| 99212 Office E&M - Established | Office | 117 | 112 | $46.57 | $5,449 |
| 78452 Myocardial Perfusion Scan | Office | 95 | 95 | $373.49 | $35K |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 95 | 95 | $76.21 | $7,240 |
| 93280 External Electrocardiographic Monitoring | Office | 81 | 33 | $27.54 | $2,231 |
| 99204 Office E&M - New | Office | 42 | 42 | $123.51 | $5,187 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 16 | 16 | $163.61 | $2,618 |
By year: 2022 $222K for 4,587 services; 2023 $205K for 3,737 services; 2024 $185K for 5,575 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thein Htay prescribed most often to Medicare patients was Metoprolol Succinate, with 982 prescriptions and refills. In total Thein Htay wrote 14,144 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 982 | 2,158 | 269 | $13K |
| Atorvastatin Calcium Generic | 898 | 2,003 | 238 | $7,408 |
| Clopidogrel Clopidogrel Bisulfate | 700 | 1,546 | 198 | $5,743 |
| Rosuvastatin Calcium Generic | 612 | 1,316 | 177 | $7,549 |
| Losartan Potassium Generic | 544 | 1,314 | 175 | $4,323 |
| Ranolazine Er Ranolazine | 530 | 1,057 | 132 | $39K |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 507 | 991 | 117 | $5,743 |
| Amlodipine Besylate Generic | 475 | 1,145 | 139 | $2,671 |
| Hydralazine Hcl Generic | 459 | 884 | 105 | $4,427 |
| Olmesartan Medoxomil Generic | 321 | 656 | 74 | $4,564 |
| Entresto Sacubitril/Valsartan | 311 | 517 | 81 | $314K |
| Montelukast Sodium Generic | 308 | 663 | 87 | $2,471 |
| Isosorbide Dinitrate Generic | 292 | 683 | 89 | $11K |
| Eliquis Apixaban | 287 | 475 | 70 | $266K |
| Ezetimibe Generic | 274 | 593 | 88 | $5,441 |
Brand drugs: - claims; generic drugs: 11,252 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thein Htay $1,461 ($1,461 in general payments such as food, travel and fees) from 18 companies. The largest payer was GlaxoSmithKline, LLC. with $187.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 9 | $187 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $167 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $153 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $151 |
| Abbvie Inc. ABBV | 6 | $148 |
| Merck Sharp & Dohme LLC MRK | 7 | $138 |
| Amgen Inc. AMGN | 4 | $104 |
| Corcept Therapeutics CORT | 2 | $70.84 |
| Esperion Therapeutics, Inc. ESPR | 3 | $69.67 |
| Madrigal Pharmaceuticals MDGL | 2 | $65.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.